February, 2003
© 2000 Scott S. Emerson, M.D., Ph.D.
Session 4: 61
Case Study 1: Idarubicin in AML
Selection of Class of Stopping Rules for Sensitivity Analysis
Study did not stop with treatment difference of 0.22 when N= 45 / arm
Study did stop with treatment difference of 0.20 when N= 65 / arm
Consider stopping boundaries that are between those two points